PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
News|Articles|April 20, 2016
BÜCHI Rotavapor R-300 Receives Design Awards
Author(s)Pharmaceutical Technology Editors
BÜCHI Rotavapor R-300 received the German Design Awards 2016, the RedDot Award 21, and the iF International Forum Design Award.
Advertisement
BÜCHI Labortechnik AG’s rotary evaporator Rotavapor R-300 received the German Design Awards 2016, the RedDot Award 21, and the iF International Forum Design Award. The User Interface I-300 and I-300 Pro for the R-300 received the iF Award in the category communication, BÜCHI said in an April 20, 2016 press announcement.
The rotary evaporator Rotavapor R-300 evaporates liquids for separation. I-300 and I-300 Pro are interfaces for the BUCHI Rotavapor R-300. Both are fully automated process controllers of all system components-attached on the rotary evaporator. The I-300 Pro offers the additional option of navigating the menu either by using the function buttons/push-wheel, the touchscreen functionality of the display, or both combined. The different modes (operating or processing) are visually separated by trough reversing the display colors.
Source: BÜCHI Labortechnik AG
Advertisement
Related to this article
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS
global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.
At PDA/FDA Joint Regulatory Conference 2026, PCI Pharma's Bassler details how a QMS overhaul turned an FDA 483 into stronger quality culture.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
2
FDA's IND Pilot Puts CMC Review First
3
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
4
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
5